DateOctober 29, 2018

UNIVERSITY OF KANSAS SCHOOL OF MEDICINE
Faculty Curriculum Vitae

  1. PERSONAL DATA

First NameStephen J.

Last nameLauer

Current Academic RankAssociate Professor, Clinical Scholar Track

Department(s)Pediatrics

Office Address3901 Rainbow Boulevard, Kansas City, KS 66160

Phone913-588-6329

Fax913-588-6167

PROFESSIONAL DEVELOPMENT

Undergraduate and Graduate Education

Years (Inclusive) / Degree / Institution
Septermber 1974 –June 1978 / B.A. Biochemistry / University of Kansas, Lawrence, Kansas
July 1978 –August 1984 / Ph. D. Biochemistry / University of Texas, Austin, Texas

Postgraduate Education

Years (Inclusive) / Degree / Institution
July 1993 –June 1997 / M.D. / University of California, Irvine, California

Academic and Professional Appointments and Activities
(List in chronological order. Please explain any discontinuity in professional experience)

Month and Year / Position / Institution
July 1978 –June 1984 / Graduate Student / Chemistry Department, University of Texas, Austin, Texas
July 1984 –August 1988 / Postdoctoral Fellow / Gladstone Foundation Laboratories, University of California, San Francisco, California
September 1988 –June 1993 / Staff Research Investigator / Gladstone Foundation Laboratories, University of California, San Francisco, California
July 1993 –June 1997 / Medical Student / University of California at Irvine, Irvine, California
July 1997 – June 2000 / Pediatric Resident / University of California, San Francisco, California
July 2000 –June 2001 / Associate Physician / University of California, San Francisco, California
July 2001 –June 2008 / Assistant Professor of Pediatrics, Clinical Scholar Track / University of Kansas Medical Center, Kansas City, Kansas
July 2008 – Current / Associate Professor of Pediatrics, Clinical Scholar Track / University of Kansas Medical Center, Kansas City, Kansas

Professional Registration/Licensure

Year / Number / State
2001 - Current / 04 – 29220 / Kansas
2007 – Current / 2007006884 / Missouri

Professional Certification(s)

Date / Board
2001 / American Board of Pediatrics
2008 / American Board of Pediatrics – Recertification
2011 / Basic Life Saving Support
2011 / Pediatrics Advanced Life Savings Support, Instructor
2011 / Neonatal Resuscitation Program

Professional Societies and Affiliations

Date / Organization (including offices held)
2001 - Current / American Academy of Pediatrics, Fellow
2001 - Current / Kansas Chapter of American Academy of Pediatrics

Honors and Awards (honorary societies, research awards, teaching and other awards)

Year / Award
1994 / Grace B. Bell Prize for Achievement in Biological Chemistry
1994 / Family Practice Department Summer Research Fellowship
1997 / Evangeline Percival Award for Excellence in Pediatrics
1997 / Election to AOA, University of California, Irvine, California
2000 / Neosozzi Award, Pediatric Residency University of California, San Francisco, California
2003 / Faculty Teaching Award, Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas
2007 / Chairman’s Award for Departmental Services, University of Kansas Medical Center, Kansas City, Kansas
2009 / Student Voice Award for Excellence in Teaching, University of Kansas Medical Center, Kansas City, Kansas
2010 / Best Doctor Kansas City Business Journal

CV for Stephen Lauer

  1. TEACHING ACTIVITIES
    (Evaluations and other evidence of quality teaching must be attached; this represents the teacher’s portfolio and should be accurately summarize ALL of your teaching activities.)
    Brief statement of areas of teaching interest:

I am interested in clinical teaching for both medical students and residents.

  1. Instruction:

Didactic (e.g.: lectures and formal presentations)

Academic
Year / Course / Title / Instruction / Student
Type / Hours / No / Type
2004 / Pediatric Clerkship / Inpatient Pediatrics / Lecture / 6 / 60 / 3rd year Medical Studuent
2005 / Pediatric Clerkship / Inpatient Pediatrics / Lecture / 6 / 60 / 3rd year Medical Studuent
2006 / Pediatric Clerkship / Inpatient Pediatrics / Lecture / 4 / 40 / 3rd year Medical Studuent
2008 / Pediatric Clerkship / Pediatric Neurology / Lecture / 9 / 90 / 3rd year Medical Studuent
2009 / Pediatric Clerkship / Inpatient Pediatrics / Lecture / 6 / 60 / 3rd year Medical Studuent

Nondidactic (e.g.: workshops, labs, and discussion groups)

Academic
Year / Course / Title / Instruction / Student
Type / Hours / No / Type
2003 - 2003 / Problem Based Learning / Discussion / 16 / 10 / 2nd Year Medical Students
2004 - 2005 / Problem Based Learning / Discussion / 14 / 10 / 2nd Year Medical Students
2005 - 2006 / Clinical Learning 2 / ICM 850 / Discussion / 14 / 12 / 2nd year Medical Students
2005 / GBS Infection in the Neonate / Maternal-Fetal Nurses Class at KUMC / Discussion / 14 / 12 / 2nd year Medical Students
2006 - 2007 / Clinical Learning 2 / ICM 850 / Discussion / 14 / 12 / 2nd year Medical Students
2007 - 2008 / Clinical Learning 2 / ICM 850 / Discussion / 4 / 12 / 2nd year Medical Student
2008 - 2009 / Problem Based Learning / M1PBL / Discussion / 12 / 12 / 1styear Medical Student
2009 - 2010 / Problem Based Learning / M1PBL / Discussion / 12 / 12 / 1st year Medical Student
2010 – 2011 / Problem Based Learning / M2PBL / Discussion / 12 / 12 / 2nd year Medical Student

Clinical

Year / Hours / Student / Length of Service
No / Type
2001 - 2002 / 160 / 100 / 3rd year Medical Students
2001 - 2002 / 160 / 100 / 3rd year Medical Students
2001 - 2002 / 84 / 9 / 3rd year Medical Students / 42 days @2 hours a day
2002 - 2003 / 160 / 100 / 3rd year Medical Students
2002 - 2003 / 84 / 9 / 3rd year Medical Students / 42 days @2 hours a day
2003 - 2004 / 160 / 100 / 3rd year Medical Students
2003 - 2004 / 84 / 9 / 3rd year Medical Students
2003 - 2004 / 20 / 1 / 2ndyear Medical Students / Entire Year
2004 - 2005 / 40 / 2 / 2ndyear Medical Students / Entire Year
2005 - 2006 / 128 / 100 / 3rd year Medical Students
2005 - 2006 / 140 / 15 / 3rd year Medical Students
2005 - 2006 / 40 / 2 / 2ndyear Medical Students / Entire Year
2006 - 2007 / 128 / 100 / 3rd year Medical Students
2006 - 2007 / 140 / 15 / 3rd year Medical Students
2006 - 2007 / 20 / 1 / 2ndyear Medical Students / Entire Year
2007 - 2008 / 50 / 50 / 3rd year Medical Students
2007 - 2008 / 140 / 15 / 3rd year Medical Students
2007 - 2008 / 20 / 1 / 2nd Year Medical Students / Entire Year
2008 - 2009 / 50 / 50 / 3rd year Medical Students
2008 - 2009 / 160 / 30 / 3rd year Medical Students
2008 - 2009 / 20 / 2 / 1st Year Medical Students / Entire Year
2009 - 2010 / 40 / 2 / 2nd year Medical Students / Entire Year
2009 - 2010 / 120 / 30 / 3rd year Medical Students / Entire Year
2010 – 2011 / 40 / 2 / 3rd year Medical Students / Entire Year

Master’s Theses and PhD Dissertations directed

Year / Student Name / Thesis Title / Degree
(Completed/In process)

Supervision of Postdoctoral Fellows

Year / Fellow Name / Area of Study

Advising (Thesis or dissertation committees: student academic group/individual)

Date / Student or group name / Type of Student/group
2008 - 2009 / Rachael Ashworth / Medical Student
2008 - 2009 / Alisa Jost / Medical Student

Other teaching activities

Date / Title / Place / Teaching Function
2002 / Adolescents Abdominal Pain / Pediatric Grand Attending Rounds / Lecture
2003 / Newborn with Rash / Pediatric Grand Attending Rounds / Lecture
2005 / ETS Exposure in children / Pediatric Grand Rounds / Formal Presentation
2006 / Discharge Summaries / GME Lecture Series / Lecture
2007 / Pediatric Rashes and Sarcoid / Pediatric Grand Attending Rounds Lecture Series / Lecture
2007 / Discharge Summaries / GME Lecture Series / Lecture
2008 / Pediatric Differences in the Academic Workforce / Pediatric Grand Rounds / Formal Presentation
2008 / Abdominal Pain in Young Females / Pediatric Grand Attending Rounds / Lecture
2010 / Mellow Yellow / Pediatric Grand Attending Rounds / Lecture
2011 / Atherosclerosis in Pediatrics / Pediatric Grand Rounds / Lecture
  1. Development of Educational Materials
    (Course materials e.g. syllabi, educational software packages, web sites, films, educational tapes and evaluation tools)

Year / Title Description / Intended Audience
2003 / Best Practices in the Diagnosis and Treatment of Childhood Obesity by Metropolitan Health Council of Greater Kansas City / Primary Care Providers
  1. Educational Leadership
    (Responsibility for courses and other leadership activities including mentoring of junior faculty. Please list faculty members mentored – letters from mentorees may be provided.)
    2008 – 2009 Worked with members of the Pediatric Residency Program to revise the goals and objectives of the Inpatient Rotation in preparation for the Residency Site Visit in January of 2009.

SERVICE ACTIVITIES
See guidelines and instructions to applicants for definitions and suggested documentation of professional and academic service.
Professional Service:

The diverse area of professional service includes patient care. Applicants should select measures that most clearly and concisely document their accomplishments and the value of these activities to the Medical School and University. Measures of both quantity and quality of activities are required and if necessary, applicants should provide brief descriptions to assist reviewers. Measures of patient care activities include numbers of patients, time allocation in clinical activity, procedures completed, Relative Value Units (RVUs), and value to the School of the clinical service. If the primary quality evaluation is the subjective assessment of peers, this should be available in letters from departmental colleagues, chair, or referees.

July 2001– January 2010 I have seen an estimated 43,200 patients in inpatient and outpatient clinic at the University of Kansas Medical Center.

I do not perform procedures.

Pediatric Department RVU Comparison

09 CFTE / FY09 work RVU Normalized 1.0 FTE
Dr. Stephen Lauer / FY09 75%tile
Pediatric Department
.40 / 10,700.23 / 4,927.08

The significance of professional service in the forms of task forces, committees and similar groups should be explained and the specific role of the applicant clarified.
Professional consulting services must have academic credibility and clear service intent and not be performed primarily for personal profit.

Academic Service:
In academic service the contribution of the candidate to the academic community should be clearly documented. Names and dates of committees, task forces, or working groups should be provided. A concise description of the significance of the group and explanation of the role of the applicant should be provided.
Activities related to Academic Societies should be documented in this section.

CV for Dr Stephen Lauer

RESEARCH and SCHOLARLY ACTIVITIES:
Brief statement of areas of research and scholarly interest, including current projects:
My primary current research interests are in the area of clinical research in the pediatric clinic and inpatient setting. I am interested in understanding the barriers to the delivery of appropriate health care in the clinic and hospital as well as understanding how to overcome those barriers by developing evidence-based guidelines that allow for the best possible health care delivery. Specific areas of interest:

a. the effects of childhood exposure to environmental tobacco smoke and barriers to parental and pediatric patient smoking cessation

b. how best to deliver effective and preventive asthma treatment and education in a pediatric clinic setting

c. how to deliver evidence-based medicine in a pediatric inpatient setting


  1. Grants and contracts
    (Information must include whether the nominee is the principal investigator or a co-investigator, names of all investigators, title of grant, funding source, dollar amount in direct costs, and years during which grant applies. Co-investigators must specify role). Provide abstracts and award notice or renewal for all grants or contracts awarded in last five years.
    Grants and contracts awarded:
    (List in chronological order)

Principal Investigator / Investigators / Title of Grant / Funding Source / Direct Costs / Years / Status
Stephen Lauer / John Taylor / "Apolipoprotein E Gene Regulation in the Developing Macrophage" / AHA / $5,000 per year / 1988 - 1991 / Complete
Stephen Lauer / Paul E. Hyman / A Multi-center Open-Labeled Study of the Safety, Efficacy and pharmacokinetics of Lubiprostone in Pediaric Patients with Constipation / Sucampo / 2008 - 2009 / Complete

Grants and contracts submitted:

Principal Investigator / Investigators / Title of Grant / Funding Source / Direct Costs / Years / Status
Stewart Babbott / 1.Stephen Lauer
2. Michael Kennedy
3. Courtney Rhudy / Developing Optimal Coordination in transitions of Care / AHRQ / - / - / Submitted

CV for Dr Stephen Lauer

  1. Scholarly Publications

Full length, peer-reviewed articles in scientific journals: (Provide names of all authors, year, title, journal, volume, and inclusive pages. List chronologically in a numbered list for each publication category.)

Articles published: (Provide a PDF of each peer-reviewed article published within the last five years. Other articles may be provided at the applicant's discretion.)

  • Lauer, S.J., Burks, E., Irving, J.D., and Ravel, J.M. (1984) Purification and characterization of three elongation factors EF-1, EF-1 and EF-2 from wheat germ. J. Biol. Chem. 259:1644-1648.
  • Browning, K.S., Yan, T.F.J., Lauer, S.J., Aquino, L.A., Tao, M., and Ravel, J.M. (1985) Phosphorylation of wheat germ initiation factors and ribosomal proteins. Plant Physiol. 77:370-373.
  • Lauer, S.J., Burks, E.A., and Ravel, J.M. (1985) Characterization of initiation factor 3 from wheat germ. 1. Effects of proteolysis on activity and subunit composition. Biochemistry 24:2924-2928.
  • Lauer, S.J., Browning, K.S., and Ravel, J.M. (1985) Characterization of initiation factor 3 from wheat germ. 2. Effects of polyclonal and monoclonal antibodies on activity. Biochemistry 24:2928-2931.
  • Lax, S.R., Lauer, S.J., Browning, K.S., and Ravel, J.M. (1986) Isolation and characterization of initiation factors from wheat germ. Methods Enzymol. 118:109-128.
  • Lauer, S.J., Walker, D., Elshourbagy, N.A., Reardon, C.A., Levy-Wilson, B., and Taylor, J.M. (1988) Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J. Biol. Chem. 263:7277-7286.
  • Wernette-Hammond, M.E., Lauer, S.J., Corsini, A., Walker, D.,Taylor, J.M., and Rall, S.C., Jr. (1989) Glycosylation of human apolipoprotein E: The carbohydrate attachment site is threonine 194. J. Biol. Chem. 264:9094-9101.
  • Boström, K., Lauer, S.J., Poksay, K., Garcia, Z., Taylor,J.M., and Innerarity, T.L. (1989) Apolipoprotein B48 RNA editing in chimeric apolipoprotein EB mRNA. J. Biol. Chem. 264:15701-15708.
  • Simonet, W.S., Bucay, N., Lauer, S.J., Wirak, D.O., Stevens, M.E., Weisgraber, K.H., Pitas, R.E., and Taylor, J.M. (1990) In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice. J. Biol. Chem. 265:10809-10812.
  • Simonet, W.S., Bucay, N., Pitas, R.E., Lauer, S.J., and Taylor, J.M. (1991) Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J. Biol. Chem. 266:8651-8654.
  • Taylor, J.M., Simonet, W.S., Bucay, N., Lauer, S.J., and de Silva, H.V. (1991) Expression of the human apolipoprotein E/apolipoprotein C-I gene locus in transgenic mice. Curr. Opinion Lipidol. 2:73-80.
  • Davis, R.W., Pierotti, V.R., Hubl, S.T., Lauer, S.J., Witztum, J.L., McLean, J.W., and Young, S.G. (1991) Lipoproteins in pinnepeds: Analysis of a high-molecular-weight form of apolipoprotein E. J. Lipid Res. 32:1013-1023.
  • Robinson, M.T., McCall, M.R., Rubin, E., Lauer, S.J., LaBelle, M., and Forte, T.M. (1992) Apolipoprotein B genetic polymorphisms in several human hepatoma derived liver cell lines. Biochem. Biophys. Res. Comm. 183: 1224-1229.
  • Jackson, S.M., Wood, L. C., Lauer, S., Taylor, J.M., Cooper, A. D., Elias, P. M., and Feingold, K.R. (1992) Effect of cutaneous permeability barrier disruption on HMG-CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice. J. Lipid Res. 33: 1307-1314.
  • Simonet, W.S., Bucay, N., Lauer, S.J., and Taylor, J.M. (1993) A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice J. Biol. Chem. 268: 8221-8229
  • Yao., Z., Lauer, S.J., Sanan, D. A., and Fazio, S. (1993) ApoA-IV is secreted on discrete HDL particles by the rat hepatoma cell line McAR-7777 transfected with apoA-IV cDNA Arteriosclerosis 13: 1476-1486.
  • deSilva, H.V., Lauer, S.J., Wang, J., Simonet, W.S., Weisgraber, K.H., Mahley, R.W., and Taylor, J.M. (1994) Overexpression of human apolipoprotoein C-III in transgenic mice results in an accumulation of apolioprotein B48 remnants that is corrected by excess apolipoprotein E. J.Biol. Chem. 269: 2324-2335.
  • Ji, Z.-S., Lauer, S.J., Fazio, S., Bensadoun, A., Taylor, J.M., and Mahley, R.W. (1994) Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J. Biol. Chem. 269: 13429-13436.
  • Fan, J.-L., Wang, J., Bensadoun, A., Lauer, S.J., Dang, Q., Mahley, R.W., and Taylor, J.M. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins (1994) Proc. Natl. Acad. Sci. USA 91: 8724-8728.

Manuscripts in press: (Provide names of all authors, title, journal, and PDF of manuscript plus evidence of acceptance by journal)

Manuscripts submitted but not yet accepted: (Provide names of all authors, title, journal, and PDF of manuscript plus evidence of receipt of manuscript by journal.)

Invited or non-peer-reviewed articles or reviews: (Provide names of all authors, year, title, journal, volume, and pages. If in press, provide documentation and PDF or article/review if published within the last five years.)

CV for Dr Stephen Lauer

Books and book chapters: (Provide names of all authors, year, book title, chapter title, edition, publisher, and pages. If in press, provide documentation and PDF or book/book chapter if published the last five years.)

  • Taylor, J.M., Chang, D.J., Leren, T.P., Walker, D., and Lauer, S.J. (1990) Regulatory elements of the apolipoprotein E gene. In: Atherosclerosis Reviews, Vol. 20, Biotechnology of Dyslipoproteinemias: Applications in Diagnosis and Control (Lenfant, C., Albertini, A., Paoletti, R., and Catapano, A.L., eds.). Raven Press, New York, pp. 47-53.
  • Taylor, J.M., Paik, Y.-K., Chang, D., Leren, T., Walker, D., and Lauer, S.J. (1990) Regulatory elements of the apolipoprotein E gene. In: Drugs Affecting Lipid Metabolism — X (Gotto, A.M., and Smith, L.C., eds.). Elsevier Science Publishers, Amsterdam, pp. 165-168.
  • Simonet, W.S., Bucay, N., Lauer, S.J., Pitas, R.E., Weisgraber, K.H., and Taylor J.M. (1990) Independent regulatory elements control expression of the human apolipoprotein E gene in the liver and kidney of transgenic mice. In: Molecular Biology of Atherosclerosis (Proceedings of the 20th International Steenbock Symposium) Elsevier Science Publishing Co., Inc., New York. pp. 3-10.
  • Simonet, W.S., Bucay, N., Lauer, S.J., Pitas, R.E., Weisgraber, K.H., and Taylor J.M. (1990) Downstream regulatory elements stimulate expression of the human aplipoprotein E gene in the liver and suppress expression in the kidney of transgenic mice. Transaction of the Association of American Physicians CIII: 119-128.
  • Swords, S., Lauer, S.J., and Nopper, A.J. Principles of Treatment in Pediatric Dermatology: Systemic Therapy in Pediatric Dermatology, 3rd edition Editors: Lawrence Schachner and Ronald Hansen, 2003

Published abstracts: (Provide names of all authors, year, title, where published, volume, and pages.)

  • Lauer, S.J., Burks, E., and Ravel, J.M. (1982) Isolation of two forms of eIF-3 from wheat germ. Fed. Proc. 41:1041.
  • Lauer, S.J. and Ravel, J.M. (1984) Effects of monoclonal antibodies on the activity of eIF-3. Fed.Proc. 43:2020.
  • Paik, Y.-K., Lauer, S.J., Levy-Wilson, B., Elshourbagy, N.A., Mahley, R.W., Reardon, C.A., and Taylor, J.M. (1985) Linkage of human apolipoprotein E and C-I genes, and expression of the apo-E promoter in cultured mammalian cells. Circulation 72:III-142.
  • Paik, Y.-K., Lauer, S.J., Chang, D., Reardon, C.A., Walker, D.W., Taxman, E., Mahley, R.W., Levy-Wilson, B., and Taylor, J.M. (1986) Regulation of human apolipoprotein E and C-I gene expression. Circulation 74:II-284.
  • Lauer, S.J., Walker, D., Levy-Wilson, B., and Taylor, J.M. (1987) There are two copies of the human apolipoprotein C-I gene linked closely downstream from the apolipoprotein E gene. Fed. Proc. 46:1948.
  • Taylor, J.M., Lauer, S.J., Paik, Y.-K., Chang, D., Taxman, E., Mahley, R.W., Weisgraber, K.H., Lau, Y.-F., and Reardon, C.A. (1987) Expression of the cloned apolipoprotein E gene after transfection into cultured cells. Fed. Proc. 46:2236.
  • Fosslein, E., Weisgraber, K.H., Lauer, S.J., Boyles, J.K.,Taylor, J.M., Bollen, A.W., Pitas, R.E., and Mahley, R.W. (1988) Apolipoprotein E and in vivo smooth muscle cell proliferation. Ann. Clin. Lab. Sci. 18:402.
  • Boström, K., Lauer, S.J., Garcia, Z., Poksay, K.S., Taylor, J.M., and Innerarity, T.L. (1989) Apolipoprotein B48 mRNA editing of chimeric apolipoprotein EB mRNA. RNA Processing, Cold Spring Harbor Laboratories, Cold Spring Harbor, New York.
  • Simonet, W.S., Bucay, N., Lauer, S.J., Wirak, D., Stevens, M., Weisgraber, K.H., Pitas, R.E., Mahley, R.W., and Taylor, J.M. (1990) In transgenic mice, distinct 5´ and 3´ regulatory elements of the human apolipoprotein E gene determine mutually exclusive high liver or abnormally high kidney expression. Clin. Res. 38:360A.
  • Simonet, W.S., Bucay, N., Lauer, S.J., de Silva, H.V., Pitas, R.E., Weisgraber, K.H., and Taylor, J.M. (1990) Multiple tissue-specific regulatory elements control the expression of the human apolipoprotein E gene in transgenic mice. Arteriosclerosis 10:773A.
  • Lauer, S.J., Simonet, W.S., Bucay, N., de Silva, H.V., and Taylor, J.M. (1991) Tissue-specific expression of the human apolipoprotein A-IV gene in transgenic mice. Arteriosclerosis 11:1390a.
  • de Silva, H.V., Lauer, S.J., Simonet, W.S., Mas-Oliva, J., Weisgraber, K.H., and Taylor, J.M. (1991) Overexpression of human apolipoprotein C-III in transgenic mice causes abnormal accumulation of low density pre--migrating apolipoprotein B48-E-AI-containing and -migrating apolipoprotein E-AI-containing lipoproteins. Arteriosclerosis 11:1391a.
  • Ramos, T.K., Lauer, S.J., Goldstone, J., and Taylor, J.M. (1992) Retroviral gene transfer of human macrophage colony stimulating factor into rabbit vascular smooth muscle cells results in expression in vitro. Circulation 86:I-472.
  • deSilva, H.V., Lauer, S.J., Wang, J., Mahley, R.W., and Taylor, J.M. (1992) Opposing effects of a apolipoprotein E and C-III on lipoprotein remnant clearance. Circulation 86: I-471.
  • Ji, J., Fazio, S., Bensadoun, A., Taylor, J.M., and Mahley, R.W. (1993) Human hepatic lipase secretio Lauer, S.J., n by transfected McA-RH7777 cells results in enhanced binding and clearance of remnant lipoproteins. Circulation 88: I-321.

Other scholarly publications